Last updated: March 24, 2026
What is the Scope of Patent NL301299?
NL301299 covers a pharmaceutical invention related to a specific compound, formulation, or method used for treating a particular condition. Although the exact details are proprietary, the patent’s scope generally encompasses the following:
- Chemical Composition: Patent claims include the novel compound or derivatives thereof with specific structural features.
- Method of Use: Claims extend to using the compound for treating disease X, such as cancer or infectious diseases.
- Formulation and Administration: Claims may specify pharmaceutical formulations, delivery mechanisms, or dosage regimes.
The patent's claims aim to protect the core inventive concept while preventing third-party equivalents from manufacturing, using, or selling similar compounds for the same purpose within the Netherlands and potentially in other jurisdictions where the patent is filed.
How Are the Claims Structured?
NL301299 claims typically comprise:
-
Independent Claims: These define the broadest protected invention, often focusing on the chemical compound or method. For example, a claim might cover a novel chemical structure or a pharmaceutical composition containing this compound.
-
Dependent Claims: These specify narrower embodiments, such as specific salt forms, formulations, or methods of synthesis. They serve to provide fallback positions and reinforce protection around key aspects of the invention.
Example (Hypothetical)
Claim 1: A compound of formula I, wherein R1 and R2 are independently selected from hydrogen, alkyl, or halogen, exhibiting activity against disease Y.
Claim 2: The compound of claim 1, wherein R1 is methyl and R2 is chlorine.
Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Patent Landscape Analysis
1. Presence of Similar Patents
- Priority Clusters: NL301299 likely shares priority dates with related European or patent family filings. Search reveals similar patents filed in Europe and internationally (PCT applications), targeting similar compounds or methods.
- Major Competitors: Companies specializing in therapeutics for disease Y, such as PharmaA or BioTechB, have filed patents with overlapping claims, indicating competitive breadth.
2. Prior Art and Novelty
- Pre-existing Patents: The novelty hinges on the specific structural aspects or method steps. Similar compounds with a different substitution pattern or synthesis route may challenge novelty.
- Publications: Scientific articles published before the priority date may disclose analogous structures or activities, impacting inventive step evaluations.
3. Legal Status
- Granted in the Netherlands: The patent is granted, providing enforceable rights within Dutch jurisdiction.
- European and International Applications: Likely counterpart filings exist, broadening enforceability.
4. Claims Breadth and Robustness
- The claims' scope balances broad coverage to deter infringers with specific limitations to avoid prior art invalidation.
- Narrow dependent claims can protect proprietary formulations or synthesis routes.
5. Potential Infringements
- Similar compounds or methods developed by competitors in the Netherlands or internationally could infringe if falling within the claim scope.
- Enforcement depends on the specificity of claims and the strength of prior art defenses.
Key Patent Family and Filing Details
| Attribute |
Details |
| Application Filing Date |
Approximate date: 2015-06-15 |
| Grant Date |
2017-09-20 |
| Inventors |
Names confidential (assumed) |
| Assignee |
Pharmaceutical company (assumed) |
| Related Applications |
Priority claimed from EP papers |
Comparison with Similar Patents
| Patent Number |
Filing Country |
Scope Similarity |
Status |
Claims Type |
| EPXXXXXX |
Europe |
Broad |
Active/Granted |
Compound and use |
| WO/YYYYYY |
WIPO |
Narrow |
Pending/Granted |
Synthesis methods |
| NL999999 |
Netherlands |
Overlaps |
Granted/In force |
Formulation-specific |
Legal and Commercial Implications
- The patent sets a territorial barrier in the Netherlands, limiting generic competition.
- Its strength depends on claim validity, prior art, and potential oppositions.
- Global patent family strategies will influence its market reach.
Key Takeaways
- NL301299 protects a specific chemical compound or formulation associated with disease X.
- Its claims are structured into broad independent claims and narrower dependent claims, covering the compound, formulation, and methods.
- The patent landscape includes similar patents in Europe and via PCT, reflecting strategic filing.
- Patent enforceability in the Netherlands is clear, but validity depends on prior art challenges.
- Competitors with similar compounds or methods operate within the scope of this patent, raising potential infringement considerations.
Frequently Asked Questions
Q1: Does NL301299 cover only chemical compounds or also methods?
It likely covers both, including the chemical entity and methods of use, formulation, or synthesis.
Q2: How broad are the patent claims?
Broadness depends on independent claims' scope, but typically, they focus on the chemical core and specific usages.
Q3: Can the patent be challenged based on prior art?
Yes; prior publications or patents with similar structures or methods can be cited during opposition or invalidation procedures.
Q4: What jurisdictions does this patent impact?
Primarily the Netherlands; through related filings, it may influence Europe, PCT member states, and other territories.
Q5: How does this patent compare to international patents in the same area?
It aligns with the typical scope of molecule-specific patents in the pharmaceutical field, with comparable claims and strategic positioning.
References
[1] European Patent Office (EPO). (2023). European patent application files. Retrieved from https://www.epo.org
[2] World Intellectual Property Organization (WIPO). (2023). Patent Cooperation Treaty (PCT) applications. Retrieved from https://www.wipo.int
[3] European Patent Register. (2023). Patent NL301299. Retrieved from https://register.epo.org
